retatrutide type 2 diabetes 🩺 in diabetes: TRANSCEND-T2D-1 Phase 3 results → HbA1c ↓2.0% + weight ↓16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. 📊💊 Ref: Lilly Retatrutide as a Novel Treatment

Neuroprotective and Neurotrophic Actions of Glucagon-Like Peptide-1: An Emerging Opportunity to Treat Neurodegenerative and Cerebrovascular Disorders

Provincial Considerations Across Canada Canadian healthcare involves both federal and provincial jurisdiction, creating a patchwork of coverage and access that varies depending on where you live

Lancet 398 (10295), 143155

Gong N, Xiao Q, Zhu B, Zhang CY, Wang YC, Fan H et al (2014) Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity

Why Hair Loss Can Feel Worse Than It Is Hair loss associated with weight loss often all over rather than in one specific area

You start low